System and method of modifying user profile in automated insulin delivery

Inventors

Ulrich, Thomas R. • Buchanan, Shaun

Assignees

Tandem Diabetes Care Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12667666-B2

Patent

Publication Date

2026-06-30

Expiration Date


Abstract

Disclosed herein are systems and methods for automated insulin delivery that provide for adaptive closed loop control that can modify the stored basal profile used by the closed loop algorithm to better reflect the user's actual needs. Actual delivery rates calculated by the closed loop algorithm can be compared to the user's stored profile. If the differences between the actual delivery rates and the stored profile are statistically significant, the stored profile can be modified.

Core Innovation

The invention describes an adaptive automated insulin-delivery system and method. The system records actual insulin delivery rates produced by a closed-loop delivery algorithm and compares their distribution with the stored, time-varying default basal profile. A Kolmogorov-Smirnov test assesses whether the distributions differ statistically significantly and identifies the time of greatest difference; the default basal profile can then be modified.

The system uses glucose levels received from a continuous glucose monitor to calculate insulin doses, employing the default basal profile within a target glucose level range and increasing or decreasing delivery from the default rate outside that range. The supplied partial content does not include the background section, so the problem being solved as stated in that section is not explicitly described in the patent.

Claims Coverage

The two independent claims are claim 1, covering an ambulatory infusion pump system, and claim 9, covering a method of diabetes therapy. Six principal inventive features summarize their claim elements; the dependent claims further describe statistical comparison and profile-modification refinements.

Ambulatory infusion pump system

Claim 1 recites a pump mechanism configured to facilitate delivery of insulin to a user, a communications interface adapted to receive glucose levels from a continuous glucose monitor, and at least one processor functionally linked to the pump mechanism and the communications interface.

Closed-loop insulin dose calculation

Claims 1 and 9 recite automatically calculating insulin doses with a closed loop delivery algorithm based on glucose levels received from a continuous glucose monitor. The algorithm employs a default basal profile when glucose levels are within a target glucose level range and is configured to increase or decrease insulin delivery from the default basal rate when glucose levels are outside that range.

Automatic insulin delivery

Claim 9 recites automatically delivering insulin to the user based on the calculated insulin doses.

Recording actual insulin delivery rates

Claims 1 and 9 recite recording actual insulin delivery rates delivered to the user based on the closed loop delivery algorithm for the plurality of times of day.

Comparing basal profile and delivery rate distributions

Claims 1 and 9 recite comparing a first distribution of the default basal profile with a second distribution of the actual insulin delivery rates to determine whether a difference between the distributions is statistically significant.

Modifying the default basal profile

Claims 1 and 9 recite modifying the default basal profile if the difference between the first and second distributions is statistically significant.

Together, the independent claims cover a pump system and a diabetes-therapy method that use continuous glucose monitor readings for closed-loop insulin dosing, record actual delivery rates, compare their distribution with the default basal profile, and modify that profile when the difference is statistically significant. The dependent claims further specify use of the Kolmogorov-Smirnov test, modification at the time of greatest difference, and comparison over a predetermined time period.

Stated Advantages

Not explicitly described in patent.

Documented Applications

A method of diabetes therapy that automatically calculates insulin doses using glucose levels received from a continuous glucose monitor and automatically delivers insulin to the user based on the calculated doses.

An ambulatory infusion pump system configured to facilitate insulin delivery to a user and use continuous glucose monitor readings in closed-loop insulin dosing.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.